ICR to study fadraciclib to treat paediatric neuroblastoma
- OPACC
- Oct 13, 2020
- 1 min read
The Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially treat the aggressive childhood cancer neuroblastoma.
Comments